OREZONE GOLD ANNOUNCES C$35 MILLION BOUGHT DEAL OFFERING

In This Article:

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./

VANCOUVER, BC, Feb. 23, 2025 /CNW/ - Orezone Gold Corporation (TSX: ORE) (OTCQX: ORZCF) (the "Company" or "Orezone") is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. (the "Underwriter"), acting as sole underwriter and bookrunner, pursuant to which the Underwriter has agreed to purchase, on a "bought deal" basis, 42,683,000 common shares of the Company (the "Common Shares") at a price of C$0.82 per Common Share (the "Offering Price"), for aggregate gross proceeds of C$35,000,060 (the "Offering").

In addition, the Company will grant the Underwriter an option to acquire up to an additional 6,402,450 Common Shares (the "Over-Allotment Option") at the Offering Price for additional gross proceeds of up to C$5,250,009, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the Closing Date (as defined herein).

The Company intends to use the net proceeds from the Offering (and any proceeds received from the Over-Allotment Option) to accelerate both the Stage II hard rock expansion and additional exploration at its Bomboré Gold Mine, as well as for working capital and general corporate purposes.

Closing of the Offering is expected to occur on or about March 13, 2025 (the "Closing Date") and is subject to certain conditions including, but not limited to, receipt of all necessary regulatory approvals, including the approval of the Toronto Stock Exchange and applicable securities regulatory authorities.

The Common Shares will be offered by way of a short form prospectus to be filed in each of the provinces of Canada (other than Quebec) and may also be sold in certain offshore jurisdictions (provided that placement in such offshore jurisdictions does not give rise to the filing of a prospectus or registration statement or to any continuous disclosure obligations) and by way of private placement in the United States pursuant to an exemption from the registration requirements of the United States Securities Act of 1933, as amended (the "U.S. Securities Act").

The securities referred to in this news release have not been, nor will they be, registered under the U.S. Securities Act, and may not be offered or sold within the United States absent U.S. registration or an applicable exemption from the U.S. registration requirements. This news release does not constitute an offer for sale of securities, nor a solicitation for offers to buy any securities in the United States, nor in any other jurisdiction in which such offer, solicitation or sale would be unlawful. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.

Waiting for permission
Allow microphone access to enable voice search

Try again.